Increased levels of DCLK1 in various human cancers including renal (Ge et al, 2018), pancreatic (Bailey et al, 2014), colorectal (Sureban et al, 2009), and liver (Nevi et al, 2021) have been correlated with cellular activities such as epithelial‐to‐mesenchymal transition, and cell proliferation and migration. This evidence concerns the gene DCLK1 and cancer.